RIPK3 and pancreatic ductal adenocarcinoma: In particular, the proteomics analysis derived from (Cao et al, 2021) shows higher levels of RIPK1 compared to RIPK3 within the Pancreatic Ductal Adenocarcinoma in both normal and tumor tissues, which is also in line with our data (Fig. EV4A).